Skip to main content

Table 5 Hematological value of female rats treated with GlucoMedix® at 28 days

From: GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome

Group/dose (mg/kg)

HCT (%)

HGB (g/dl)

WBC Differential Counting

RBC x106cell/ul

WBC x103cell/ul

NEU

MONO

EOS

LYM

%

(%)

(%)

(%)

250

41.06 ± 1.14

13.66 ± 0.44

60.2 ± 1.64

4.60 ± 1.14

2.80 ± 0.84

31.00 ± 3.08

4.46 ± 0.27

6.26 ± 0.23

1000

42.98 ± 3.61

13.70 ± 0.34

58.00 ± 2.55

4.80 ± 1.30

2.40 ± 0.55

34.80 ± 2.95

4.92 ± 0.24

6.10 ± 0.19

2000

43.24 ± 0.42 *

14.48 ± 0.53

60.20 ± 1.10

4.20 ± 1.30

2.60 ± 0.55

29.80 ± 4.60

4.70 ± 0.32

6.08 ± 0.24

Control

40.08 ± 0.80

13.32 ± 0.51

60.40 ± 1.14

4.40 ± 0.89

2.60 ± 0.55

31.60 ± 2.07

4.64 ± 0.32

6.08 ± 0.22

  1. Values are expressed as mean ± SD. n = 5. Parameters include hematocrit (HCT), hemoglobin (HGB), neutrophils (NEU), monocytes (MON), eosinophils (EOS), lymphocytes (LYM), red blood cells (RBC), and white blood cells (WBC). * p < 0.05 compared to control group